| BCBS Federal Medical & Drug | 5.90.034 Topical Products with Quantity Limits | 2025-09-19 |
| BCBS Federal Medical & Drug | 5.90.037 Qbrexza (glycopyrronium) | 2025-09-19 |
| BCBS Federal Medical & Drug | 5.90.042 Qutenza (capsaicin patch) | 2025-09-19 |
| BCBS Federal Medical & Drug | 5.90.043 Scenesse (afamelanotide) | 2025-09-19 |
| BCBS Federal Medical & Drug | 5.90.047 Winlevi (clascoterone) | 2025-09-19 |
| BCBS Federal Medical & Drug | 5.90.075 Zevaskyn (prademagene zamikeracel) | 2025-09-19 |
| BCBS Federal Medical & Drug | 5.99.032 Ryoncil (remestemcel-L-rknd) | 2025-09-19 |
| Medicare CGS | Billing and Coding: Transcatheter Infusion Therapy (56811) | 2025-09-19 |
| Medicare CGS | Billing and Coding: MolDX: Biomarkers in Cardiovascular Risk Assessment (57386) | 2025-09-19 |
| Aetna | Tisagenlecleucel (Kymriah) | 2025-09-18 |